Related to UCB and Plasticell Partner to Identify Compounds for SC Research and Cell Therapeutics

• Researchers Awarded $2.4M to Study Neuronal Regeneration
  
• Scientists Pinpoint a Way to Stimulate Bone Formation Independent of Bone Destruction
  
• Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research
  
• BioMimetic Strengthens Arrangement with Novartis for Exclusive Supply of Recombinant Human Platelet-Derived Growth Factor
  
• New U.K. Center for Regenerative Medicine to Receive Over $13M in Funding
  
• Adocia Raises Over $20M to Take BioChaperone Growth-Factor Treatments into Phase I Trials
  
• TAP and Centre for Innovative Manufacturing in Regenerative Medicine Ink Five-Year Extension
  
• American Medical Systems and Tissue Genesis to Study Regenerative Potential of Adipose Cells in Pelvic Health Disorders
  
• Corning and Sartorius Stedim Biotech to Provide Combined Cell-Culture Product Catalog
  
• UT-Battelle Licenses Tissue-Regeneration Technologies to NellOne Therapeutics
  
• Scientists Develop Method to Screen Large Compound Libraries
  
• Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discovery
  
• International Stem Cell Opens Production Site for Clinical-Grade Stem Cell Products
  
• University of Cardiff Spin-Out to Develop Cell-Based Cartilage-Replacement Therapy
  
• Investigators Come Up with Virus-Free Technique to Make Stem Cells Pluripotent
  
• ReNeuron Raises £4.7M to Fund Phase I Study with Stem Cell Therapy for Ischemic Stroke
  
• Yecuris Introduces Humanized Mouse Knockout Model for In Vivo Hepatocyte Expansion
  
• Xcellerex to Develop Single-Use Manufacturing Technology for Humacyte’s Vascular Grafts
  
• Evotec to Screen for Hits against Active Biotech Immune Disorder and Cancer Target
  
• TAP Negotiates Additional Distribution Rights to Aviso’s Automated Stem Cell Picker